Author/Authors :
Gheith, Osama Department of Nephrology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Wafa, Ehab Department of Nephrology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Refaie, Ayman Department of Nephrology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Hassan, Nabil Department of Nephrology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Mostafa, Amani Department of Immunology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Sheashaa, Hussein Department of Nephrology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Shokeir, Ahmaed Department of Urology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Kamal, Mohamed Department of Urology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt , Ghoneim, Mohamed A Department of Urology - Urology and Nephrology Center - Mansoura University - Mansoura, Egypt
Abstract :
The prevalence of post-transplantation anemia
(PTA) ranges between 20 and 60% depending on the
criteria used for defining anemia, not only that, it is
also a common problem in pediatric studies (1, 2). The
three recent surveys enrolling the largest number of
patients reported a prevalence of 30-40%. Severe anemia,
requiring treatment based on current guidelines is less
frequent with prevalence rate of 10-15%
